Loading insider details...
Beta
Latest Form 4 (Jul 24, 2026): Tax Withholding of 15,405 VYNE shares, $13.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 15,405 | $13.8K |
| Jul 3, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 2,370 | $1.5K |
| Apr 2, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 2,876 | $1.7K |
| Jan 5, 2026 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 2,448 | $1.4K |
| Oct 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 2,453 | $821.75 |
| Jul 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 2,453 | $4.0K |
| Apr 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 6,044 | $9.5K |
| Jan 23, 2025 | VYNE Therapeutics Inc. (VYNE) | Grant/Award | 230,000 | n/a |
| Jan 2, 2025 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 4,857 | $16.3K |
| Oct 2, 2024 | VYNE Therapeutics Inc. (VYNE) | Tax Withholding | 109 | $204.92 |